Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial. - Alsaleh, K.; Al Zahwahry, H.; Bounedjar, A.; Oukkal, M.; Saadeddine, A.; Mahfouf, H.; Bouzid, K.; Bensalem, A.; Filali, T.; Abdel-Razeq, H.; Larbaoui, B.; Kandil, A.; et al. (Journal of Cancer Research & Clinical Oncology, 2023)